Total | Low Cr excretion | High Cr excretion | P | |
---|---|---|---|---|
n | 210 | 105 | 105 | |
Male (%) | 126 (60%) | 41 (39%) | 85 (81%) | < 0.01 |
Age | 52.5 (16–85) | 57 (16–85) | 47 (17–77) | < 0.01 |
BSA (m2) | 1.63 (1.20–2.20) | 1.52 (1.20–2.13) | 1.73 (1.46–2.20) | < 0.01 |
U-Cr (mg/day) | 1025 (413–2012) | 843 (413–1019) | 1260 (1031–2012) | < 0.01 |
Cr (mg/dL) | 1.13 (0.45–6.31) | 1.00 (0.45–6.31) | 0.80 (0.45–2.62) | n.s. |
Cys (mg/L) | 1.24 (0.52–5.67) | 1.27 (0.60–5.67) | 0.98 (0.52–2.37) | n.s. |
CIn (mL/min/1.73 m2) | 55.5 (6.0–147.0) | 49.0 (6.0–147.0) | 61.0 (19.0–147.0) | < 0.01 |
CCr (mL/min/1.73 m2) | 68.0 (8.5–167.3) | 57.5 (8.5–167.3) | 75.7 (24.1–158.7) | < 0.01 |
eGFRCr (mL/min/1.73 m2) | 51.0 (7.9–144.4) | 48.2 (7.9–144.4) | 55.0 (16.2–138.1) | n.s. |
eGFRCys (mL/min/1.73 m2) | 60.0 (5.7–181.2) | 53.0 (5.7–142.0) | 62.1 (13.2–181.2) | < 0.05 |
eGFRCr+Cys (mL/min/1.73 m2) | 54.8 (7.3–153.1) | 51.6 (7.3–143.2) | 59.9 (14.7–153.1) | n.s. |
eGFR-CKDEPICr (mL/min/1.73 m2) | 57.7 (7.1–118.4) | 54.1 (7.1–118.4) | 61.3 (15.1–116.1) | n.s. |
CCr-CIn (mL/min/1.73 m2) | 10.6 (− 50.5–78.4) | 8.5 (− 50.5–78.4) | 12.6 (− 23.4–71.8) | n.s. |
eGFRCr-CIn (mL/min/1.73 m2) | − 5.0 (− 56.2–41.4) | 0.3 (− 42.4–40.3) | − 10.0 (− 56.2–41.4) | < 0.01 |
eGFRCys-CIn (mL/min/1.73 m2) | 3.0 (− 51.0–57.5) | 2.9 (− 51.0–57.5) | 4.2 (− 32.1–56.3) | n.s. |
eGFRCr+Cys-CIn (mL/min/1.73 m2) | − 0.6 (− 41.1–48.9) | 0.4 (− 41.1–44.2) | − 1.7 (− 40.5–48.9) | n.s. |
eGFR-CKDEPICr-CIn (mL/min/1.73 m2) | − 2.4 (− 46.8–47.4) | − 0.4 (− 44.6–44.6) | − 7.0 (− 46.8–47.4) | < 0.01 |